River Wealth Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

River Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-850	Closed	-$21K	–	609
2018 Q2	$21K	Buy	+850	New	+$17.3K	0.01%	350
2017 Q4	–	Sell	-11,398	Closed	-$201K	–	165
2017 Q3	$201K	Sell	11,398 -14,502	-56%	-$326K	0.09%	153
2017 Q2	$860K	Sell	25,900 -2,281	-8%	-$70.6K	0.4%	87
2017 Q1	$904K	Sell	28,181 -6,402	-19%	-$218K	0.44%	80
2016 Q4	$1.25M	Buy	34,583 +24,709	+250%	+$987K	0.63%	61
2016 Q3	$454K	Buy	9,874 +8	+0.1%	+$417	0.25%	112
2016 Q2	$496K	Buy	9,866 +757	+8%	+$40.3K	0.28%	101
2016 Q1	$487K	Buy	9,109 +257	+3%	+$15.1K	0.29%	98
2015 Q4	$581K	Buy	8,852 +796	+10%	+$49.2K	0.37%	89
2015 Q3	$455K	Sell	8,056 -296	-4%	-$19.2K	0.31%	99
2015 Q2	$494K	Buy	8,352 +429	+5%	+$26.5K	0.31%	100
2015 Q1	$494K	Buy	+7,923	New	+$461K	0.31%	103

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

River Wealth Advisors's TEVA Position: Q3 2018 in Review

River Wealth Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2018, closing a stake of 850 shares — an estimated $21K sold.

River Wealth Advisors first reported a position in TEVA in Q1 2015 and held it in 12 quarters. The position peaked at $1.25M in Q4 2016. 556 funds tracked by Wall St. Rank hold TEVA as of Q3 2018.

River Wealth Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2018 after selling out during the quarter.
River Wealth Advisors sold 850 Teva Pharmaceutical Industries Limited shares in Q3 2018, an estimated $21K.
River Wealth Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q1 2015 and held it in 12 quarters.
River Wealth Advisors's Teva Pharmaceutical Industries Limited position peaked at $1.25M in Q4 2016.
556 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2018.

Based on River Wealth Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.